IL188022A0 - Benzofuranone derivatives as nonsteroidal progesterone receptor modulators - Google Patents

Benzofuranone derivatives as nonsteroidal progesterone receptor modulators

Info

Publication number
IL188022A0
IL188022A0 IL188022A IL18802207A IL188022A0 IL 188022 A0 IL188022 A0 IL 188022A0 IL 188022 A IL188022 A IL 188022A IL 18802207 A IL18802207 A IL 18802207A IL 188022 A0 IL188022 A0 IL 188022A0
Authority
IL
Israel
Prior art keywords
receptor modulators
progesterone receptor
benzofuranone derivatives
nonsteroidal progesterone
nonsteroidal
Prior art date
Application number
IL188022A
Other languages
English (en)
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of IL188022A0 publication Critical patent/IL188022A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • C07D307/88—Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/94—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom spiro-condensed with carbocyclic rings or ring systems, e.g. griseofulvins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/83—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Furan Compounds (AREA)
IL188022A 2005-06-24 2007-12-10 Benzofuranone derivatives as nonsteroidal progesterone receptor modulators IL188022A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005030294A DE102005030294A1 (de) 2005-06-24 2005-06-24 Nichtsteroidale Progesteronrezeptor-Modulatoren
PCT/EP2006/006532 WO2006136462A1 (en) 2005-06-24 2006-06-22 Benzofuranone derivatives as nonsteroidal progesterone receptor modulators

Publications (1)

Publication Number Publication Date
IL188022A0 true IL188022A0 (en) 2008-03-20

Family

ID=36716643

Family Applications (1)

Application Number Title Priority Date Filing Date
IL188022A IL188022A0 (en) 2005-06-24 2007-12-10 Benzofuranone derivatives as nonsteroidal progesterone receptor modulators

Country Status (22)

Country Link
EP (1) EP1899315A1 (no)
JP (1) JP2008543911A (no)
KR (1) KR20080018275A (no)
CN (1) CN101248056A (no)
AR (1) AR057409A1 (no)
AU (1) AU2006261049A1 (no)
BR (1) BRPI0612305A2 (no)
CA (1) CA2611900A1 (no)
CR (1) CR9595A (no)
DE (1) DE102005030294A1 (no)
DO (1) DOP2006000150A (no)
EA (1) EA200702604A1 (no)
EC (1) ECSP078043A (no)
GT (1) GT200600272A (no)
IL (1) IL188022A0 (no)
MX (1) MX2008000070A (no)
NO (1) NO20080441L (no)
PE (1) PE20070170A1 (no)
TW (1) TW200738665A (no)
UY (1) UY29626A1 (no)
WO (1) WO2006136462A1 (no)
ZA (1) ZA200800689B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY30805A1 (es) * 2006-12-21 2008-07-31 Bayer Schering Pharma Ag Moduladores no esteroides de receptores de progesterona
DE102007032800A1 (de) * 2007-07-10 2009-01-15 Bayer Schering Pharma Aktiengesellschaft Nichtsteroidale Progesteronrezeptor-Modulatoren
DE102007058747A1 (de) 2007-12-05 2009-06-10 Bayer Schering Pharma Aktiengesellschaft Nichtsteroidale Progesteronrezeptor-Modulatoren
TWI477276B (zh) * 2008-04-28 2015-03-21 Repros Therapeutics Inc 抗黃體素給藥方案
ES2701400T3 (es) 2012-05-31 2019-02-22 Repros Therapeutics Inc Formulaciones para la administración vaginal de antiprogestinas
EP2914268B1 (en) 2012-11-02 2018-07-04 Repros Therapeutics Inc. Methods and compositions for treating progesterone-dependent conditions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19723722A1 (de) * 1997-05-30 1998-12-10 Schering Ag Nichtsteroidale Gestagene
CA2371273A1 (en) * 1999-05-04 2000-11-09 Andrew Fensome Tetracyclic progesterone receptor modulator compounds and methods
US6358948B1 (en) * 1999-05-04 2002-03-19 American Home Products Corporation Quinazolinone and benzoxazine derivatives as progesterone receptor modulators
CA2472746A1 (en) * 2002-01-14 2003-07-24 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them and uses thereof
DK1482925T3 (da) * 2002-03-11 2007-05-14 Bayer Schering Pharma Ag 5- (2-hydroxy-3 -'1 - (3-trifluormethylphenyl) cyclopropylpropionylamino) phtalid og relaterede forbindelser med progesteronreceptormoducerende aktivitet til anvendelse i fertilitetskontrol og hormonerstatningsterapi
DE10346939A1 (de) * 2003-10-06 2005-05-19 Schering Ag Heterocyclisch substituierte Pentanole, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer

Also Published As

Publication number Publication date
KR20080018275A (ko) 2008-02-27
NO20080441L (no) 2008-03-07
AR057409A1 (es) 2007-12-05
TW200738665A (en) 2007-10-16
AU2006261049A1 (en) 2006-12-28
CA2611900A1 (en) 2006-12-28
EP1899315A1 (en) 2008-03-19
CR9595A (es) 2008-05-05
DE102005030294A1 (de) 2007-01-04
JP2008543911A (ja) 2008-12-04
ZA200800689B (en) 2009-07-29
BRPI0612305A2 (pt) 2010-11-03
ECSP078043A (es) 2008-01-23
DOP2006000150A (es) 2006-12-31
EA200702604A1 (ru) 2008-06-30
PE20070170A1 (es) 2007-03-02
WO2006136462A1 (en) 2006-12-28
UY29626A1 (es) 2007-01-31
GT200600272A (es) 2007-08-20
MX2008000070A (es) 2008-03-19
CN101248056A (zh) 2008-08-20

Similar Documents

Publication Publication Date Title
IL178767A0 (en) Indolyl derivatives as liver - x - receptor modulators
HK1129108A1 (en) Indoles as 5-ht6 modulators 5-ht6
IL188039A0 (en) Oxindole derivatives
IL184657A0 (en) Adam-9 modulators
GB0400440D0 (en) Receptor modulators
ZA200609234B (en) Substituted azeplne derivatives as serotonin receptor modulators
IL191767A0 (en) Imidazoles as gaba-b receptor modulators
HK1134089A1 (en) Tetrahydrocyclopenta[b]indole compounds as androgen receptor modulators
IL193176A0 (en) Benzoyl-piperidine derivatives as 5ht2/d3 modulators
HK1138852A1 (en) Indozalyl sulphonamide derivatives useful as glucocorticoid modulators
IL191766A0 (en) Gaba-b receptor modulators
IL189846A0 (en) Theramutein modulators
EP1915162A4 (en) MODULATORS
IL191710A0 (en) Glucocorticoid receptor modulators as antiinflammatory agents
ZA200903235B (en) Novel Triazinedione Derivatives as Gaba-b receptor modulators
ZA200800689B (en) Benzofuranone derivatives as nonsteroidal progesterone receptor modulators
ZA200804871B (en) Estrogen modulators
GB0622569D0 (en) Cannabinoid receptor modulators
ZA200705107B (en) Selected benzofuran derivatives
ZA200800690B (en) Non-steroidal progesterone receptor modulators
ZA200806810B (en) Benzoyl-piperidine derivatives as 5HT2/D3 modulators
IL184532A0 (en) Novel adenosine a3 receptor modulators
ZA200806237B (en) Cannibinoid receptor modulators
AP2008004481A0 (en) Estrogen modulators
HK1131787A1 (en) Oxa-steroids derivatives as selective progesterone receptor modulators